(Q38039167)

27 August 2017

title

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations (English)

1 reference

27 August 2017

2

1 reference

27 August 2017

3

Steven A Narod

1 reference

27 August 2017

Amy Finch

1

1 reference

27 August 2017

publication date

1 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

543-555

1 reference

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

27 August 2017

cites work

1 reference

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.

21 January 2018

1 reference

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.

21 January 2018

1 reference

Increased risk of recurrence after hormone replacement therapy in breast cancer survivors

21 January 2018

1 reference

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.

21 January 2018

1 reference

Increased cardiovascular mortality after early bilateral oophorectomy

21 January 2018

1 reference

Menopause and the risk of coronary heart disease in women

21 January 2018

1 reference

Surgical menopause and cardiovascular risks

21 January 2018

1 reference

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.

21 January 2018

1 reference

Premature menopause or early menopause and risk of ischemic stroke

21 January 2018

1 reference

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy

21 January 2018

1 reference

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

21 January 2018

1 reference

BRCA1 is an essential regulator of heart function and survival following myocardial infarction

21 January 2018

1 reference

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

21 January 2018

1 reference

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing

21 January 2018

1 reference

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.

21 January 2018

1 reference

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

21 January 2018

1 reference

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

21 January 2018

1 reference

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

21 January 2018

1 reference

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations

21 January 2018

1 reference

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

21 January 2018

1 reference

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

21 January 2018

1 reference

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature

21 January 2018

1 reference

High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy

21 January 2018

1 reference

Pathologic findings in prophylactic oophorectomy specimens in high-risk women

21 January 2018

1 reference

Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk

21 January 2018

1 reference

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

21 January 2018

1 reference

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

21 January 2018

1 reference

Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy

21 January 2018

1 reference

Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

21 January 2018

1 reference

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol

21 January 2018

1 reference

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

21 January 2018

1 reference

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

21 January 2018

1 reference

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development

21 January 2018

1 reference

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.

21 January 2018

1 reference

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer

21 January 2018

1 reference

What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy

21 January 2018

1 reference

Osteoporosis after oophorectomy for non-malignant disease in premenopausal women.

21 January 2018

1 reference

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

21 January 2018

1 reference

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Menopause and risk of cardiovascular disease: the Framingham study.

21 January 2018

1 reference

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

21 January 2018

1 reference

Premature menopause or early menopause: long-term health consequences

21 January 2018

1 reference

Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis

21 January 2018

1 reference

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

21 January 2018

1 reference

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

21 January 2018

1 reference

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

21 January 2018

1 reference

Hormone replacement therapy and the risk of breast cancer

21 January 2018

1 reference

Breast cancer after use of estrogen plus progestin in postmenopausal women

21 January 2018

1 reference

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

21 January 2018

1 reference

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy

21 January 2018

1 reference

Androgen deficiency in the oophorectomized woman

21 January 2018

1 reference

Influence of estrogen plus testosterone supplementation on breast cancer

21 January 2018

1 reference

Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer

21 January 2018

1 reference

The incidence of invasive breast cancer among women prescribed testosterone for low libido.

21 January 2018

1 reference

Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy

21 January 2018

1 reference

Androgens and breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.12.41

1 reference

27 August 2017

1 reference